FDA Clears Siemens’ CT Scanner for the Budget-Conscious
The FDA cleared Siemens’ 128-slice CT scanner designed as a budget-conscious option for community and critical access hospitals and outpatient centers.
The FDA has cleared Siemens Healthcare’s new 128-slice CT scanner designed as a budget-conscious option for community hospitals, critical access hospitals, and outpatient centers, the company announced.
The Somatom Perspective includes their Sinogram Affirmed Iterative Reconstruction (SAFIRE) method for CT image reconstruction, which helps users reduce dose by up to 60 percent compared to other filtered back projection techniques, the company said. With reconstruction speed of up to 15 images per second, SAFIRE can be used in daily clinical routines.
The Somatom Perspective also includes an eMode feature, created to determine and automatically select parameters so the CT operates with as low a load as possible to minimize wear and increase the scanner’s life cycle, the company said. It also has Fully Assisting Scanner Technologies (FAST) to simplify and automate complex procedures.
The Somatom Perspective can scan long ranges rapidly, making it ideal for thoracic examination, and it can potentially image all body regions, widening clinical capabilities. Somatom’s slim gantry and 194-square-foot gantry allows it to be installed in small rooms, and it requires less electricity than other CT systems, the company said. The system, which is available with service and leasing options tailored to the community hospital, can usually be installed in one day.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
